If you are comparing tirzepatide vs. semaglutide in Houston, understanding their differences can help you prepare for a medical consultation. Tirzepatide activates GIP and GLP-1 receptors, while semaglutide targets GLP-1. Both can support appetite control and are used alongside nutrition and physical activity.
In the SURMOUNT-5 trial, adults with obesity without diabetes lost an average of 20.2% of body weight with tirzepatide versus 13.7% with semaglutide over 72 weeks at maximum tolerated doses. These are study averages, not guaranteed outcomes. Individual progress depends on treatment tolerance, adherence, health history, and lifestyle.
For adults considering tirzepatide weight loss in Houston, TX, eligibility generally includes a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure. A clinician must also review medications, medical history, and potential risks.
Tirzepatide is not appropriate during pregnancy or for people with a personal or family history of medullary thyroid cancer or MEN 2. Common side effects include nausea, diarrhea, and constipation.
At Rodriguez Rejuvenation, a consultation can help you explore treatment options and discuss realistic goals. Ask about follow-up visits, nutrition support, and a long-term maintenance plan before deciding which approach best fits your needs.
Tirzepatide activates GIP and GLP-1 receptors, while semaglutide activates GLP-1 receptors. Both can help regulate appetite. The appropriate treatment depends on your medical history, treatment goals, tolerability, and a clinician’s assessment.
In the 72-week SURMOUNT-5 trial, adults with obesity without diabetes lost an average of 20.2% of body weight with tirzepatide at maximum tolerated doses. Individual results vary, and this study average does not guarantee your outcome.
Test our treatments for yourself with our AI Aesthetic Simulator.